Repositioning Candidate Details

Candidate ID: R1108
Source ID: DB06826
Source Type: approved; investigational
Compound Type: small molecule
Compound Name: Unoprostone
Synonyms: 13,14-dihydro-15-keto-20-ethyl PGF2α; Unoprostone
Molecular Formula: C22H38O5
SMILES: CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(O)=O
Structure:
DrugBank Description: Unoprostone isopropyl is a prostaglandin analogue. Ophthalmic Solution 0.15% is a synthetic docosanoid. Unoprostone isopropyl has the chemical name isopropyl (+)-(Z)-7--5-heptenoate. The main indication of Unoprostane is treatment of glucoma.
CAS Number: 120373-36-6
Molecular Weight: 382.541
DrugBank Indication: For the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another intraocular pressure lowering medication.
DrugBank Pharmacology: Unoprostone will begin to reduce IOP 30 minutes after ocular instillation.
DrugBank MoA: Unoprostone is believed to reduce elevated intraocular pressure (IOP), by increasing the outflow of aqueous humor. The mechanism of action for the IOP-lowering effect of unoprostone is controversial. Early studies showed that unoprostone increases aqueous humor outflow through the uveoscleral pathway similar to the 20-carbon prostaglandin analogs, such as latanoprost.8 More recent evidence, however, shows that it may work, at least in part, through stimulation of Ca2+-activated BK and CIC-2 type channels, leading to increased trabecular meshwork outflow.
Targets: --
Inclusion Criteria: Indication associated